Skip to main content
Premium Trial:

Request an Annual Quote

Donald Halbert, Steven Salzberg, Graham Fleming, Pier Oddone, Toni Schuh, Richard Kniss


Donald Halbert has joined Iconix Pharmaceuticals as executive vice president of research and development, the company said last week.

Halbert joins Iconix from Abbott Laboratories, where he was director of genomics, proteomics, and bioinformatics in the global pharmaceutical research and development group. In addition, he was chairman of the Abbott-Iconix scientific advisory committee, overseeing the two companies’ 2003 alliance. Previously, he held scientific and management positions at Becton Dickinson. Halbert has a PhD in molecular virology from Washington University in St. Louis.

Steven Salzberg, senior director of bioinformatics at The Institute for Genomic Research, will be leaving his post this summer to serve as director of the center for bioinformatics and computational biology at the University of Maryland, according to BioInform, an Inside Bioassays sister publication.

Graham Fleming will be the new deputy director of Lawrence Berkeley National Laboratory, Berkeley Lab said last week. He will replace Pier Oddone, who will become director of the Fermi National Accelerator Laboratory in July. Fleming has been the lab’s physical biosciences division director. He holds a PhD in chemistry from the University of London.

Arcturus Bioscience has appointed Toni Schuh as CEO, the Mountain View, Calif.-based firm said this week. Schuh will also be elected to Arcturus’ board of directors, the company said.

Schuh joins Arcturus from Sequenom, where he served as CEO from May 2000 to February 2005. He has also served as managing director of Sequenom GmbH, the company’s initial operations in Germany, as well as its executive vice president of business development.

Arcturus also announced this week that Richard Kniss, an Arcturus board member since 2002, will be appointed non-executive chairman. Kniss was senior vice president and general manager of the life science and chemical group of Agilent Technologies prior to his retirement in 2001 after 34 years with Agilent and Hewlett Packard, Arcturus said.


The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.